Показано 0 из 0
Дата |
---|
02.07.2024 |
01.07.2024 |
28.06.2024 |
27.06.2024 |
26.06.2024 |
25.06.2024 |
24.06.2024 |
21.06.2024 |
20.06.2024 |
18.06.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
360.00
|
652.93
|
437.14
|
429.27
|
444.49
|
435.49
|
|
|
125 709 318.08
|
8 751.00
|
423.25
|
444.04
|
430.45
|
428.97
|
438.12
|
434.22
|
|
|
143 019 905.17
|
8 388.00
|
422.17
|
439.23
|
432.69
|
428.76
|
439.12
|
430.04
|
|
|
232 681 886.01
|
14 015.00
|
440.25
|
668.07
|
445.88
|
443.45
|
448.93
|
444.94
|
|
|
115 105 334.98
|
7 413.00
|
440.05
|
673.44
|
453.235
|
444.61
|
456.676883
|
445.88
|
|
|
139 664 940.40
|
10 577.00
|
437.50
|
679.51
|
455.76
|
448.24
|
455.76
|
451.55
|
|
|
226 768 519.16
|
14 181.00
|
437.50
|
661.21
|
439.99
|
428.92
|
445.245
|
440.59
|
|
|
408 902 542.85
|
21 618.00
|
390.20
|
414.30
|
391.56
|
387.035
|
399.49
|
394.47
|
|
|
220 987 673.26
|
12 802.00
|
192.84
|
409.00
|
382.90
|
379.39
|
388.12
|
387.87
|
|
|
98 556 845.05
|
8 254.00
|
370.87
|
385.58
|
378.38
|
377.48
|
383.36
|
377.96
|
|
|
96 045 171.16
|
7 098.00
|
Argenx S.E., a clinical-stage biopharmaceutical company, focuses on developing antibody-based therapies for the treatment of autoimmune diseases and cancer.